AdditionalTabText object
Additional Information
In accordance with Art. 49 of the Federal Health Insurance Act, the research costs in the framework of clinical trials are not borne by health insurance schemes. The costs of the test and comparator products (IMPs) and all other trial-related examinations must therefore be borne by the sponsor.
